Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial

Fertility and Sterility

Volumn 68, Issue 6, 1997, Pages 981-986

  Hirata, Janie D ^a   Small, Rebecca ^c   Swiersz, Lillian M ^b   Ettinger, Bruce ^d   Zell, Bonnie ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d DIVISION OF RESEARCH   (United States)

Author keywords

Alternative therapy; Climacteric; Dong quai; Herbal therapy

Indexed keywords

FOLLITROPIN; HERBACEOUS AGENT; PLACEBO;

ADULT; ARTICLE; CELL MATURATION; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; ESTROGEN DEFICIENCY; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HUMAN EXPERIMENT; POSTMENOPAUSE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; TRANSVAGINAL ECHOGRAPHY; VASOMOTOR REFLEX;

DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; ENDOMETRIUM; ESTRADIOL; ESTRONE; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; SEX HORMONE-BINDING GLOBULIN; TREATMENT FAILURE; VAGINA;

EID: 0031438945     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)00397-X     Document Type: Article

References (18)

1. 1. Utian WH, Schiff I. NAMS-Gallup survey on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapy. Menopause 1994;1:39-48.
2. 2. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-52.
3. 3. Chang H-M, But PPH. Pharmacology and applications of Chinese materia medica, Vol 1. Yao S-C, Wang L-L, Yeung SC-S, translators. Singapore: World Scientific, 1986:489-505.
4. 4. Wilbur P. The phyto-oestrogen debate. Eur J Herbal Med 1996;2(2):20-6.
5. 5. Wied GL. Female genital tract: hormonal cytology. In: Keebler CM, Reagan JW, editors. Manual of cytotechnology, 5th ed. Chicago: American Society of Clinical Pathologists, 1977; 63-86.
6. 6. Blair OM. Hormonal cytopathology of the vagina. In: Gold JJ, Josimovich JB, editors. Gynecologic endocrinology, 4th ed. New York: Plenum, 1987:159-73.
7. 7. Meisels A. The maturation value [letter]. Acta Cytol 1967; 11:249.
8. 8. Blatt MHG, Wiesbader H, Kupperman HS. Vitamin E and climacteric syndrome: failure of effective control as measured by menopausal index. Arch Intern Med 1953;91:792-9.
9. 9. Blaustein RL. Cytology of the female genital tract. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract, 3rd edition. New York: Springer-Verlag, 1987:895.
10. 10. Ettinger B, Bainton L, Upmalis DH, Citron JT, VanGessel A. Comparison of endometrial growth produced by unopposed conjugated estrogens or by micronized estradiol in postmenopausal women. Am J Obstet Gynecol 1997;176:112-7.
11. 11. Baird DD, Umbach DM, Landsell L, Hughes CL, Setchell KDR, Weinberg CR, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995;80:1685-90.
12. 12. Utian WH. Comparative trial of P1496, a new non-steroidal oestrogen analogue. Br Med J 1973;1:579-81.
13. 13. Semmens JP, Tsai CC, Semmens EC, Loadholt CB. Effects of estrogen therapy on vaginal physiology during menopause. Obstet Gynecol 1985;66:15-8.
14. 14. Geola FL, Prumar AM, Tataryn IV, Lu KH, Hershman JM, Eggena P, et al. Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 1980;51:620-5.
15. 15. Sporrong T, Hellgren M, Samsioe G, Mattsson LA. Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints. Br J Obstet Gynaecol 1988;95:1042-8.
16. 16. Jensen J, Christiansen C. Dose-response and withdrawal effects on climacteric symptoms after hormonal replacement therapy: a placebo-controlled therapeutic trial. Maturitas 1983;5:125-33.
17. 17. Loprinzi CL, Michalak JC, Quella SK, O'Fallon JR, Hatfield AK, Nelimark RA, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med 1994;331:347-52.
18. 18. Lindsay R, Hart DM. Failure of response of menopausal vasomotor symptoms to clonidine. Maturitas 1978;1:21-5.